Public disclosures

Salovey Peter

Company insiders · Director · Legend Biotech Corp

Advertisement
FollowLatest SEC filingSEC filer historyProfile details as reported on 2026-11-16.Following & alerts
Reported transaction lines
2
Buy lines
2
Sell lines
0

Filing activity by month

Original filing lines in up to 12 months with activity.

  • 2026-112

Frequently disclosed stocks

Disclosure history

More filters
Clear filters
Reporting investorSecurityActivityTransaction / periodFiledReported amountSource
Salovey Peter

Director · Legend Biotech Corp

LEGN

Legend Biotech Corp

Buy
Filing details

SEC transaction code P

Ordinary Shares · Direct ownership · Reported balance after transaction: 75096 · SEC code covers open-market or private transactions · The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. · The price reported in Column 4 represents the converted purchase price of the ADSs of $17.90 per ADS.

2026-11-132026-11-16

≈ $89,500.00

10,000 shares/units

SEC 4
Salovey Peter

Director · Legend Biotech Corp

LEGN

Legend Biotech Corp

Buy
Filing details

SEC transaction code P

Ordinary Shares · Direct ownership · Reported balance after transaction: 65096 · SEC code covers open-market or private transactions · The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. · The price reported in Column 4 represents the converted purchase price of the ADSs of $18.75 per ADS.

2026-11-122026-11-16

≈ $93,750.00

10,000 shares/units

SEC 4

Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.

Advertisement